5
Views
0
CrossRef citations to date
0
Altmetric
Articles

Peritubular Capillary Loss Is Ameliorated by Ramipril or Valsartan Treatment

, , , , &
Pages 337-348 | Published online: 10 Jul 2009

REFERENCES

  • Wolf G, Butzmann U, Wenzel U O. The renin-angiotensin system and progression of renal disease: from hemodynamics to cell biology. Nephron Physiol 2003; 93: p3–p13
  • Jafar T H, Stark P C, Schmid C H, Landa M, Maschio G, de Jong P E, de Zeeuw D, Shahinfar S, Toto R, Levey A S, AIPRD Study Group. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med 2003; 139: 244–252
  • Atkins R C, Briganti E M, Lewis J B, Hunsicker L G, Braden G, Champion de Crespigny P J, DeFerrari G, Drury P, Locatelli F, Wiegmann T B, Lewis E J. Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy. Am J Kidney Dis 2005; 45: 281–287
  • Nangaku M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol 2006; 17: 17–25
  • Manotham K, Tanaka T, Matsumoto M, Ohse T, Miyata T, Inagi R, Kurokawa K, Fujita T, Nangaku M. Evidence of tubular hypoxia in the early phase in the remnant kidney model. J Am Soc Nephrol 2004; 15: 1277–1288
  • Norman J T, Stidwill R, Singer M, Fine L G. Angiotensin II blockade augments renal cortical microvascular pO2 indicating a novel, potentially renoprotective action. Nephron Physiol 2003; 94: p39–p46
  • Lombardi D, Gordon K L, Polinsky P, Suga S, Schwartz S M, Johnson R J. Salt-sensitive hypertension develops after short-term exposure to Angiotensin II. Hypertension 1999; 33: 1013–1019
  • Shao J, Nangaku M, Miyata T, Inagi R, Yamada K, Kurokawa K, Fujita T. Imbalance of T-cell subsets in angiotensin II-infused hypertensive rats with kidney injury. Hypertension 2003; 42: 31–38
  • Ibrahim H N, Hostetter T. The renin-aldosterone axis in two models of reduced renal mass in the rat. J Am Soc Nephrol 1998; 9: 72–76
  • Shimizu A, Kitamura H, Masuda Y, Ishizaki M, Sugisaki Y, Yamanaka N. Rare glomerular capillary regeneration and subsequent capillary regression with endothelial cell apoptosis in progressive glomerulonephritis. Am J Pathol 1997; 151: 1231–1239
  • Ohashi R, Kitamura H, Yamanaka N. Peritubular capillary injury during the progression of experimental glomerulonephritis in rats. J Am Soc Nephrol 2000; 11: 47–56
  • Kim Y G, Suga S, Kang D H, Jefferson J A, Mazzali M, Gordon K L, Matsui K, Breiteneder-Geleff S, Shankland S J, Hughes J, Kerjaschki D, Schreiner G F, Johnson R J. Vascular endothelial growth factor stimulates vascular remodeling and tissue repair in a model of thrombotic microangiopathy. Kidney Int 2000; 58: 2390–2399
  • Kang D H, Joly A H, Oh S W, Hugo C, Kerjaschki D, Gordon K L, Mazzali M, Jefferson J A, Hughes J, Madsen K M, Schreiner G F, Johnson R J. Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol 2001; 12: 1434–1447
  • Bohle A, von Gise H, Mackensen-Haen S, Stark-Jakob B. The obliteration of the postglomerular capillaries and its influence upon the function of both glomeruli and tubuli. Functional interpretation of morphologic findings. Klin Wochenschr 1981; 59: 1043–1051
  • Choi Y J, Chakraborty S, Nguyen V, Nguyen C, Kim B K, Shim S I, Suki W N, Truong L D. Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: Altered expression of vascular endothelial growth factor. Hum Pathol 2000; 31: 1491–149
  • YuanH-T, LiX-Z, Pitera J E, Long D A, Woolf A S. Peritubular capillary loss after mouse acute nephrotoxicity correlates with down-regulation of vascular endothelial growth factor-A and hypoxia-inducible factor-1alpha. Am J Pathol 2003; 163: 2289–230
  • Kairaitis L K, Wang Y, Gassmann M, Tay Y C, Harris D C. HIF-1alpha expression follows microvascular loss in advanced murine adriamycin nephrosis. Am J Physiol Renal Physiol 2005; 288: F198–F20
  • Colman R W. Regulation of angiogenesis by the kallikrein-kinin system. Curr Pharm Des 2006; 12: 2599–260
  • Agodoa L Y, Appel L, Bakris G L, Beck G, Bourgoignie J, Briggs J P, Charleston J, Cheek D, Cleveland W, Douglas J G, Douglas M, Dowie D, Faulkner M, Gabriel A, Gassman J, Greene T, Hall Y, Hebert L, Hiremath L, Jamerson K, Johnson C J, Kopple J, Kusek J, Lash J, Lea J, Lewis J B, Lipkowitz M, Massry S, Middleton J, Miller E R, 3rd, Norris K, O'Connor D, Ojo A, Phillips R A, Pogue V, Rahman M, Randall O S, Rostand S, Schulman G, Smith W, Thornley-Brown D, Tisher C C, Toto R D, Wright J T, Jr, Xu S, African American Study of Kidney Disease and Hypertension (AASK) Study Group. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA 2001; 285: 2719–2728
  • Wright J T, Jr., Bakris G, Greene T, Agodoa L Y, Appel L J, Charleston J, Cheek D, Douglas-Baltimore J G, Gassman J, Glassock R, Hebert L, Jamerson K, Lewis J, Phillips R A, Toto R D, Middleton J P, Rostand S G, African Am Study of Kidney Disease and Hypertension Study Group. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA 2002; 288: 2421–2431
  • Ruggenenti P, Perna A, Benini R, Remuzzi G, for the “gruppo italiano di studi epidemiologici in nefrologia” (GISEN). Effects of dihydropyridine calcium channel blockers, angiotensin-converting enzyme inhibition, and blood pressure control on chronic, nondiabetic nephropathies. J Am Soc Nephrol 1998; 9: 2096–2101
  • Brenner B M, Cooper M E, de Zeeuw D, Keane W F, Mitch W E, Parving H H, Remuzzi G, Snapinn S M, Zhang Z, Shahinfar S, RENAAL Study Investigators. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861–869
  • Safran M, Kaelin W G. HIF hydroxylation and the mammalian oxygen-sensing pathway. J Clin Invest 2003; 111: 779–78
  • Rosenberger C, Mandriota S, Jurgensen J S, Wiesener M S, Horstrup J H, Frei U, Ratcliffe P J, Maxwell P H, Bachmann S, Eckardt K U. Expression of hypoxia-inducible factor-1alpha and-2alpha in hypoxic and ischemic rat kidneys. J Am Soc Nephrol 2002; 13: 1721–1732
  • Griffin K A, Picken M M, Churchill M, Churchill P, Bidani A K. Functional and structural correlates of glomerulosclerosis after renal mass reduction in the rat. J Am Soc Nephrol 2000; 11: 497–506
  • Fine L G, Bandyopadhay D, Norman J T. Is there a common mechanism for the progression of different types of renal disease other than proteinuria? Towards the unifying theme of chronic hypoxia. Kidney Int 2000; 57: S22–S26, [Suppl 75]
  • Norman J T, Clark I M, Garcia P. Hypoxia promotes fibrogenesis in human renal fibroblast. Kidney Int 2000; 58: 2351–2366
  • Orphanides C, Fine L G, Norman J T. Hypoxia stimulates proximal tubular cell matrix production via TGF-β 1 independent mechanism. Kidney Int 1997; 52: 637–647
  • Tanaka T, Hanafusa N, Ingelfinger J R, Ohse T, Fujita T, Nangaku M. Hypoxia induces apoptosis in SV40-immortalized rat proximal tubular cells through the mitochondrial pathways, devoid of HIF1-mediated upregulation of Bax. Biochem Biophys Res Commun 2003; 309: 222–231
  • Tanaka T, Miyata T, Inagi R, Kurokawa K, Adler S, Fujita T, Nangaku M. Hypoxia-induced apoptosis in cultured glomerular endothelial cells: Involvement of mitochondrial pathways. Kidney Int 2003; 64: 2020–2032
  • Manotham K, Tanaka T, Matsumoto M, Ohse T, Inagi R, Miyata T, Kurokawa K, Fujita T, Ingelfinger J R, Nangaku M. Transdifferentiation of cultured tubular cell induced by hypoxia. Kidney Int 2004; 65: 871–880
  • Loutzenhiser R D, Epstein M, Fischetti F, Horton C. Effects of amlodipine on renal hemodynamics. Am J Cardiol 1989; 64: 122I–127I

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.